Brent A. Johnson, Ph.D
Registered Patent Attorney • Shareholder
Education
J.D., Whittier Law School
Ph.D., University of California, Los Angeles, Chemistry
B.S., Brigham Young University, Chemistry
Expertise
IP Procurement and Portfolio Management • Patent Prosecution • Post Grant Proceedings • Freedom to Operate • Due Dilligence
Brent Johnson is a shareholder in the firm’s Orange County office. He focuses his practice on intellectual property matters. Areas of practice include patent prosecution, BPAI post grant proceedings, IP due diligence, Import/Export issues related to IP, and client counseling, particularly in the areas of pharmaceutical technologies, medical devices and other chemistry-related technology.
Dr. Johnson manages and procures IP portfolios in the life sciences and other chemistry and material-based technologies. Previously, he was a partner at a large international law firm, and a patent attorney at another high end IP Southern California-based boutique firm. He began his IP career as a patent agent at Allergan, Inc., where he managed patent portfolios for pharmaceutical products representing about $1 billion in annual sales, such as Lumigan®, Alphagan®, Combigan®, Restasis®, and others. Prior to his legal career, Dr. Johnson worked as a research chemist at an LA-based chemical company. He earned a Ph.D. at UCLA, where he studied the influence of quantum mechanical tunneling in a photochemical hydrogen transfer reaction for various ortho-methylarylketones that he synthesized.
-
Technical Experience
Pharmaceuticals
Ophthalmics
Life Sciences
Medical devices
Drug delivery systems
Prostaglandins
Retinoids
Alpha adrenergics
Cannabinoids
Organophosphorous compounds
NSAIDS
Steroids
Cyclodextrins
Cyclosporins
Opioids
Neurotoxins
Semiconductors
Photocatalysts
Light-emitting materials
Charge transport materials
Ceramics
Graphenes
Polymers
Coatings
Adhesives
Surfactants
Halocarbons
Rocket fuels
-
Representative Matters
Patent No. 9,309,237 “HIV inhibitors”
Patent No. 7,399,868 “4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones Acting as Alpha 2 Adrenergic Agonists”
Patent No. 7,323,463 “Combination of Brimonidine and Timolol for Topical Ophthalmic Use”
Patent Publication No. 20100213831 “Ambipolar Host In Organic Light Emitting Diode”
Patent No. 7,763,341 “Filled Polymer Composite and Synthetic Building Material Composition
BioMagic, Inc. v. Dutch Brothers Enterprises – patent license arbitration and patent infringement lawsuit related to odor control compositions
-
Professional Admissions & Associations
United States Patent and Trademark Office
California State Bar
J. Reuben Clark Law Society
American Chemical Society
-
Publications & Presentations
“Strategic and Practical Considerations for Accelerated Examination in the United States,” Patent Lawyer Magazine (March/April 2022)
“Hey, That’s My Invention! Avoiding Costly Ownership Mistakes With IP,” The Orange County Business Journal (October 1, 2020)
-
Awards & Recognition
Patexia Insights – Ranked #13, Best Performing Attorney in Biotech
Southern California Super Lawyers Rising Stars (2014-2018)